Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
addressing, adjuvant, advisor, agonist, altogether, Amercia, Amneal, Andersen, antagonist, appealed, Armistice, Arthur, Assertio, ATM, Ave, Axsome, Becton, blended, Boulder, breast, brochure, brokerage, BTIG, Cadence, Calcitonin, Camana, cancer, Cantor, Carolina, carryforward, caution, Cayman, CCPA, Cefaly, CGRP, chair, Christine, Circuit, clarifying, cluster, Codification, Colorado, Computershare, Corcept, Currax, DEA, Dear, debarment, Deloitte, detention, deterioration, Dickinson, Dihydroergotamine, disclaimer, dismissal, dismissed, dissatisfied, Dublin, electroCore, emotional, Endocrinology, eNeura, entail, epidemic, episodic, expedient, explain, Fiduciary, Fitzgerald, flat, franchise, frequency, furniture, gathered, GDPR, Genentech, Grand, Greenville, Hal, headcount, Hedging, heightened, Herceptin, higher, Hofliger, Impel, implicit, incremental, Inovio, instance, intracutaneously, intraperiod, IQ, Ireland, Janssen, Jersey, lab, Lo, Lundbeck, marginal, MAST, MBS, Merck, Mintz, Mountainview, move, MSA, NA, NeuroPharma, North, Noven, NY, Ogier, orphan, outbreak, overseen, paresthesia, persistent, perspective, pervasive, Pfizer, Pharmaceutica, potency, precautionary, preliminary, proportion, prorated, purity, QtryptaTM, qualification, questionnaire, quickly, reaction, reassessed, remanded, rescue, residual, resubmit, RGP, River, RLD, Road, room, route, Sabby, Saddle, Satsuma, Schorr, social, Society, strength, subcutaneously, subgroup, sumatriptan, suspected, SVWMF, swelling, tablet, taxation, Telemetry, temperature, Theranica, therapy, timeline, Tmax, top, topline, Touche, unannounced, unconstitutional, underwritten, vacant, verification, viewed, visit, vitro, Wainwright, weigh, widespread
Removed:
acceleration, Avidity, BioMed, bioorganic, BMV, Bruce, CNS, correct, death, dental, Draft, effected, encouraging, Erbez, exert, formal, Georgia, GLP, graduated, improvement, indirect, intangible, Intellikine, intramuscular, judgmental, Kura, Lamba, legacy, mITT, multiplied, nonemployee, Nordisk, noted, Novo, packing, Pantec, par, participating, plc, pledge, pro, promissory, proposal, rata, Realty, regained, reimbursable, representative, satisfied, Secretary, secured, stating, Steel, stringent, subordinated, Takeda, Thirteen, Troy, Trump, Tso, typical, unsecured, updated, urgent, Vikram, vision, Wellspring, wholly, Winnie, Zogenix
Filing tables
Filing exhibits
Related press release
ZSANQ similar filings
Filing view
External links
Exhibit 23.2
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT
We consent to the incorporation by reference in the Registration Statements on Form S-3 (File No. 333-213567 and 333-229686) and Form S-8s (File Nos. 333-203039, 333-218502, 333-225527 and 333-233284) of our report (which includes an emphasis of matter paragraph as to the Company’s ability to continue as a going concern) dated March 12, 2020, with respect to our audit of the financial statements of Zosano Pharma Corporation as of December 31, 2019 and for the year-ended December 31, 2019 appearing in the Annual Report on Form 10-K of Zosano Pharma Corporation for the year ended December 31, 2019.
By: | /s/ Deloitte & Touche LLP | |
Deloitte & Touche LLP | ||
San Francisco, CA | ||
March 12, 2020 |